Prognostic significance of FXYD-3 in Patients who underwent resection of Colorectal Liver Metastases
Access status:
Open Access
Type
ArticleAuthor/s
Bhimani, NazimAbstract
Background: Colorectal cancer (CRC) is the third most common cancer in Australia and approximately 50% of these patients will eventually develop colorectal liver metastases (CRLM) [1-3]. Many organs such as the breast, pancreas, lung, stomach and rectum have varying expression ...
See moreBackground: Colorectal cancer (CRC) is the third most common cancer in Australia and approximately 50% of these patients will eventually develop colorectal liver metastases (CRLM) [1-3]. Many organs such as the breast, pancreas, lung, stomach and rectum have varying expression levels of FXYD-3. There are conflicting results from studies examining the relationship between FXYD-3 expression and CRC, and to date there have been no studies on the expression of FXYD-3 in CRLM. Aims: The aim of this study is to determine the prevalence of FXYD-3 expression in patients with primary CRC and those that develop CRLM, and determine if FXYD-3 expression is associated with survival after resection of CRLM.
See less
See moreBackground: Colorectal cancer (CRC) is the third most common cancer in Australia and approximately 50% of these patients will eventually develop colorectal liver metastases (CRLM) [1-3]. Many organs such as the breast, pancreas, lung, stomach and rectum have varying expression levels of FXYD-3. There are conflicting results from studies examining the relationship between FXYD-3 expression and CRC, and to date there have been no studies on the expression of FXYD-3 in CRLM. Aims: The aim of this study is to determine the prevalence of FXYD-3 expression in patients with primary CRC and those that develop CRLM, and determine if FXYD-3 expression is associated with survival after resection of CRLM.
See less
Date
2019-05-03Licence
The author retains copyright of this workDepartment, Discipline or Centre
Biostatistics, School of Public HealthShare